Clinical Trial Update: Study of Copeptin as a Diagnostic Marker for Acute Pancreatitis

View source ↗

Summary

The trial evaluating copeptin as a diagnostic biomarker for acute pancreatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatitis

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Acute Pancreatitis, Pancreatitis | Status: COMPLETED